On a roll in Ireland, Alexion plots 200-job supply chain hub

Alexion ($AXLN), like many of its pharma peers, has moved some operations to Ireland to enjoy the country's low tax rate. Now, it's beefing up those operations: Thursday, the rare-disease drugmaker announced plans for its third Irish project, a new supply-chain facility that should produce around 200 jobs come 2016. More

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

Novartis and Incyte will put their blockbuster JAK inhibitor into phase 3 clinical trials as a possible treatment for COVID-19, the drugmakers said.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.